Literature DB >> 2394131

Retroviral RNA packaging: sequence requirements and implications.

M L Linial1, A D Miller.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2394131     DOI: 10.1007/978-3-642-75218-6_5

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  73 in total

1.  Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging.

Authors:  M Heinkelein; J Thurow; M Dressler; H Imrich; D Neumann-Haefelin; M O McClure; A Rethwilm
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Role of RNA in facilitating Gag/Gag-Pol interaction.

Authors:  Ahmad Khorchid; Rabih Halwani; Mark A Wainberg; Lawrence Kleiman
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Functional characterization of the dimer linkage structure RNA of Moloney murine sarcoma virus.

Authors:  H Ly; D P Nierlich; J C Olsen; A H Kaplan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Link between genome packaging and rate of budding for Rous sarcoma virus.

Authors:  Eric M Callahan; John W Wills
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  7SL RNA is retained in HIV-1 minimal virus-like particles as an S-domain fragment.

Authors:  Sarra E Keene; Steven R King; Alice Telesnitsky
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  RNA and protein requirements for incorporation of the Pol protein into foamy virus particles.

Authors:  Katrin Peters; Tatiana Wiktorowicz; Martin Heinkelein; Axel Rethwilm
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Role of the gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA.

Authors:  S Oertle; P F Spahr
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.

Authors:  J Luban; S P Goff
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA.

Authors:  J L Certo; B F Shook; P D Yin; J T Snider; W S Hu
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.

Authors:  C Lavallée; X J Yao; A Ladha; H Göttlinger; W A Haseltine; E A Cohen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.